e-lek
[Top] [All Lists]

[e-lek] Fwd: [e-drug] Webinar: Regulating drug prices: national and global implications of Canada's recent reforms

---------- Forwarded message ---------
From: Marcela Vieira <marcelacfvieira@gmail.com>
Date: Tue, 10 Dec 2019 at 00:19
Subject: [e-drug] Webinar: Regulating drug prices: national and global
implications of Canada's recent reforms
To: Essential Drugs in English <e-drug@healthnet.org>


E-DRUG: Webinar: Regulating drug prices: national and global implications
of Canada's recent reforms
------------------------------------------------------------------------------------------

Dear e-druggers,

Tuesday, December 17, 4pm - 5pm CET / 10am-11am EST
We would like to invite you to the next webinar of the series organized by
the Knowledge Network for Innovation and Access to Medicines, a project of
the Global Health Centre at the Graduate Institute of Geneva.

We hope you will be able to join us for this discussion. The webinar will
be recorded and made available a few days after it takes place. A list of
the previous webinars of the series and their recordings and related
materials is available at:
https://www.knowledgeportalia.org/webinars

Regulating drug prices: national and global implications of Canada's
recent reforms

Tuesday, December 17, 4pm - 5pm CET / 10am-11am EST

To join the webinar, please register here:
https://zoom.us/webinar/register/3015759185706/WN_--zbZyi-SP2hTSCtam3wQA

Speaker: Elena Lungu, Manager of Policy Development, Patented Medicine
Prices Review Board (PMPRB), Canada

The Canadian Government has recently amended its Patented Medicine
Regulations bringing significant changes to the way in which it regulates
the prices of patented drugs.

Canada's regulatory framework was originally adopted by
Parliament in 1987 through changes to the Patent Act that sought to balance
stronger patent protection for pharmaceuticals with a mechanism to ensure
their prices remain reasonable.

The Patented Medicine Prices Review Board (PMPRB) was conceived as an
independent, quasi-judicial agency to protect consumers from excessive
prices. Nevertheless, today Canada has the third-highest medicines prices
in the world, behind the United States and Switzerland, with OECD prices
generally being 19% below Canadian prices.

Three decades after, the PMPRB now has new tools and information to
consider in its price regulatory review, including
 i) a new basket of
comparator countries for external reference pricing;
ii) consideration of value and overall affordability of a medicine and
iii) regulating at the level of the actual prices being paid in Canada,
reflective of confidential discounts provided to payers.

Canada's Minister of Health called the reform 'the biggest step to lower
drug prices in a generation'.

The PMPRB's Elena Lungu will present the motivations for the reform, most
substantive changes in the existing regulation, and expected results once
the amendments come into force on 1 July 2020, from the perspective of the
regulatory agency charged with implementing them.

The webinar is free and open to the public and will be held in English.
Participants will be able to pose questions orally or in writing, and the
speakers will respond to a selection of these during the second half of the
event. Recordings of all webinars will be made available at the Knowledge
Portal on Innovation and Access to Medicines. After registering, you will
receive a confirmation email with additional information on how to join
the webinar using the Zoom platform.

This is part of the webinar series of the Knowledge Network for Innovation
and Access to Medicines, a project of the Global Health Centre at the
Graduate Institute, Geneva.

Related materials from the Knowledge Network on Innovation and Access to
Medicines:

-        Research synthesis on price controls/regulation
<https://www.knowledgeportalia.org/price-controls-regulation>

-        Webinar - Addressing high drug prices - what can be learned from
European policies?
<
https://graduateinstitute.ch/communications/events/webinar-addressing-high-drug-prices-what-can-be-learned-european-policies
>,
presented by Sabine Vogler, Austrian Public Health Institute (G?G)

Marcela Vieira
Researcher and Project Coordinator of the
Knowledge Network for Innovation and Access to Medicines
https://www.knowledgeportalia.org/
Global Health Centre, Research
Graduate Institute of International and Development Studies
marcela.vieira@graduateinstitute.ch
Marcela Vieira <marcelacfvieira@gmail.com>
_______________________________________________
E-Drug, an e-forum on essential drugs, is moderated by a team of
international experts and hosted by FHI 360

To subscribe:  e-drug-join@healthnet.org
To unsubscribe:  e-drug-leave@healthnet.org
To discuss (subscribers only):  e-drug@healthnet.org
For help:  e-drug-owner@healthnet.org
For archives:  http://lists.healthnet.org/archive/html/e-drug/
<Prev in Thread] Current Thread [Next in Thread>
  • [e-lek] Fwd: [e-drug] Webinar: Regulating drug prices: national and global implications of Canada's recent reforms, Liliya Eugenevna Ziganshina <=